We are live on ! Find out more
Daiwa Securities Group

Daiwa Securities Group Portfolio holdings

AUM $34.8B
1-Year Est. Return 20.7%
This Fund
S&P 500
This Quarter Est. Return
+6.66%
1 Year Est. Return
+20.7%
3 Year Est. Return
+66.64%
5 Year Est. Return
+79.21%
10 Year Est. Return
+192.59%
AUM
$15.1B
AUM Growth
+$742M
Cap. Flow
-$196M
Cap. Flow %
-1.3%
Top 10 Hldgs %
36.33%
Holding
1,380
New
61
Increased
578
Reduced
366
Closed
37

Top Buys

Rank Stock Value
1
SPG icon
Simon Property Group
SPG
+$105M
2
SUI icon
Sun Communities
SUI
+$103M
3
IRM icon
Iron Mountain
IRM
+$96M
4
KIM icon
Kimco Realty
KIM
+$95.3M
5
MPT
Medical Properties Trust
MPT
+$80.5M

Top Sells

Rank Stock Value
1
PSA icon
Public Storage
PSA
+$213M
2
WELL icon
Welltower
WELL
+$143M
3
REXR icon
Rexford Industrial Realty
REXR
+$139M
4
DLR icon
Digital Realty Trust
DLR
+$40.5M
5
INVH icon
Invitation Homes
INVH
+$37.1M

Sector Composition

Rank Sector Weight
1 Real Estate 54.29%
2 Technology 12.23%
3 Consumer Discretionary 4.83%
4 Communication Services 4.52%
5 Healthcare 4.28%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
BBIO icon
1126
BridgeBio Pharma
BBIO
$16.5B
$9K ﹤0.01%
550
-7,747
-93% -$117K
BEAM icon
1127
Beam Therapeutics
BEAM
$2.58B
$9K ﹤0.01%
283
– –
NUVL
1128
DELISTED
Nuvalent
NUVL
$9K ﹤0.01%
205
– –
MORF
1129
DELISTED
Morphic Holding, Inc. Common Stock
MORF
$9K ﹤0.01%
155
– –
KDNY
1130
DELISTED
Chinook Therapeutics, Inc. Common Stock
KDNY
$9K ﹤0.01%
230
– –
DICE
1131
DELISTED
DICE Therapeutics, Inc. Common Stock
DICE
$9K ﹤0.01%
192
– –
HRMY icon
1132
Harmony Biosciences
HRMY
$2.08B
$8K ﹤0.01%
239
– –
MYGN icon
1133
Myriad Genetics
MYGN
$515M
$8K ﹤0.01%
326
– –
ZLAB icon
1134
Zai Lab
ZLAB
$2.1B
$8K ﹤0.01%
278
– –
RVNC
1135
DELISTED
Revance Therapeutics, Inc.
RVNC
$8K ﹤0.01%
331
– –
MRTX
1136
DELISTED
Mirati Therapeutics, Inc. Common Stock
MRTX
$8K ﹤0.01%
232
– –
ABCL icon
1137
AbCellera Biologics
ABCL
$1.6B
$7K ﹤0.01%
1,151
– –
CVAC
1138
DELISTED
CureVac
CVAC
$7K ﹤0.01%
697
-6,215
-90% -$55.6K
GMAB icon
1139
Genmab
GMAB
$17.7B
$7K ﹤0.01%
172
– –
PCRX icon
1140
Pacira BioSciences
PCRX
$1.04B
$7K ﹤0.01%
169
– –
SMMT icon
1141
Summit Therapeutics
SMMT
$10.5B
$7K ﹤0.01%
2,728
– –
SPXL icon
1142
Direxion Daily S&P 500 Bull 3x ETF
SPXL
$6.53B
– –
0
– –
SUPN icon
1143
Supernus Pharmaceuticals
SUPN
$2.73B
$7K ﹤0.01%
217
– –
SWTX
1144
DELISTED
SpringWorks Therapeutics
SWTX
$7K ﹤0.01%
251
– –
VCYT icon
1145
Veracyte
VCYT
$4.44B
$7K ﹤0.01%
266
– –
VTYX
1146
DELISTED
Ventyx Biosciences
VTYX
$7K ﹤0.01%
228
– –
ACLX
1147
DELISTED
Arcellx
ACLX
$6K ﹤0.01%
176
– –
AGIO icon
1148
Agios Pharmaceuticals
AGIO
$2.2B
$6K ﹤0.01%
204
– –
AMLX icon
1149
Amylyx Pharmaceuticals
AMLX
$2.17B
$6K ﹤0.01%
266
– –
IMCR icon
1150
Immunocore
IMCR
$1.72B
$6K ﹤0.01%
104
– –
44 45
46
47 48

Similar funds

SAM
Storebrand Asset Management Lysaker, Norway $34.8B AUM 25.49% 1-Year Est. Return
Chevy Chase Trust
Chevy Chase Trust Bethesda, Maryland $34.7B AUM 29.45% 1-Year Est. Return
William Blair & Company
William Blair & Company Chicago, Illinois $34.9B AUM 18.88% 1-Year Est. Return
VIA
Vanguard Investments Australia Victoria, Australia $34.6B AUM
Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return
Parnassus Investments
Parnassus Investments San Francisco, California $34.1B AUM 20.22% 1-Year Est. Return
Kayne Anderson Rudnick Investment Management
Kayne Anderson Rudnick Investment Management Los Angeles, California $34B AUM 6.31% 1-Year Est. Return
Pacer Advisors
Pacer Advisors Malvern, Pennsylvania $35.6B AUM 18.19% 1-Year Est. Return

Daiwa Securities Group's Q2 2023 Portfolio in Review

As of Q2 2023, Daiwa Securities Group held 1,380 positions worth $15.1B, up 5.2% from $14.4B the previous quarter. Its ten largest holdings account for 36% of the portfolio.

Daiwa Securities Group's Q2 2023 filing shows 61 new, 578 increased, 366 reduced and 37 closed positions. Its largest new stake was Applovin: 95,413 shares worth $2.46M. The largest sale was Public Storage, an estimated $213M.

By sector, the portfolio is most concentrated in Real Estate at 54% of assets, down from 55% a quarter earlier, followed by Technology and Consumer Discretionary.

  • Daiwa Securities Group's largest Q2 2023 buy was Applovin: 95,413 shares worth $2.46M.
  • Daiwa Securities Group added most to Simon Property Group in Q2 2023, an estimated $105M increase.
  • Daiwa Securities Group's biggest Q2 2023 reduction was Public Storage, cutting an estimated $213M.
  • Daiwa Securities Group fully exited BWX Technologies in Q2 2023, selling an estimated $6.7M.
  • Daiwa Securities Group's ten largest holdings make up 36% of its $15.1B portfolio in Q2 2023.
  • Daiwa Securities Group opened 61 new positions and closed 37 in Q2 2023.
  • Daiwa Securities Group's portfolio value rose 5.2% quarter-over-quarter to $15.1B.

Based on Daiwa Securities Group's 13F filing for Q2 2023, filed 31 Jul 2023.